J. von Jan

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

S. Mustjoki, T. Haferlach, T. Brümmendorf, 2018, Nature Communications.

Advances and Perspectives in the Treatment of T-PLL

M. Herling, J. von Jan, T. Braun, 2020, Current Hematologic Malignancy Reports.

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

T. Aittokallio, D. Mougiakakos, M. Hallek, 2020, Blood.

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine

T. Aittokallio, S. Mustjoki, S. Timonen, 2020, Leukemia.

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

S. Mustjoki, T. Haferlach, T. Brümmendorf, 2018, Nature Communications.

Non-canonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

T. Aittokallio, D. Mougiakakos, M. Hallek, 2020, Blood.

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

T. Aittokallio, S. Mustjoki, S. Timonen, 2021, Journal of medicinal chemistry.

Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies

R. Herwig, M. Peifer, M. Hallek, 2022, Blood.